Synthesis, physicochemical characterization, toxicity and efficacy of a PEG conjugate and a hybrid PEG conjugate nanoparticle formulation of the antibiotic moxifloxacin
dc.contributor.author | Dube, Admire | |
dc.contributor.author | Tshweu, Lesego L. | |
dc.contributor.author | Shemis, Mohamed Abbas | |
dc.date.accessioned | 2020-12-15T07:39:07Z | |
dc.date.available | 2020-12-15T07:39:07Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Antibiotic resistance is increasing at such an alarming rate that it is now one of the greatest global health challenges. Undesirable toxic side-effects of the drugs lead to high rates of non-completion of treatment regimens which in turn leads to the development of drug resistance. We report on the development of delivery systems that enable antibiotics to be toxic against bacterial cells while sparing human cells. | en_US |
dc.identifier.citation | 17. Dube, A. et al. (2020). Synthesis, physicochemical characterization, toxicity and efficacy of a PEG conjugate and a hybrid PEG conjugate nanoparticle formulation of the antibiotic moxifloxacin. RSC Advances,10(34),19770-19780 | en_US |
dc.identifier.issn | 2046-2069 | |
dc.identifier.uri | 10.1039/c9ra10872f | |
dc.identifier.uri | http://hdl.handle.net/10566/5512 | |
dc.language.iso | en | en_US |
dc.publisher | Royal Society of Chemistry | en_US |
dc.subject | PEG conjugate | en_US |
dc.subject | Hybrid PEG conjugate | en_US |
dc.subject | Antibiotic | en_US |
dc.subject | Drugs | en_US |
dc.subject | Moxifloxacin | en_US |
dc.title | Synthesis, physicochemical characterization, toxicity and efficacy of a PEG conjugate and a hybrid PEG conjugate nanoparticle formulation of the antibiotic moxifloxacin | en_US |
dc.type | Article | en_US |